e-learning
resources
Berlin 2001
Wednesday 26.09.2001
Immune deficiencies and the lung in childhood
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung manifestations of chronic granulomatous disease; a clinical survey of patients from the Iranian primary immunodeficiency registry
A. Aghamohammadi, A. Farhoudi, M. Moein, M. Movahedi, N. Shahnavaz, A. Babaei Jandaghi, N. Rezaei, K. Abolmaali (Tehran, Iran)
Source:
Annual Congress 2001 - Immune deficiencies and the lung in childhood
Session:
Immune deficiencies and the lung in childhood
Session type:
Oral Presentation
Number:
3431
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Aghamohammadi, A. Farhoudi, M. Moein, M. Movahedi, N. Shahnavaz, A. Babaei Jandaghi, N. Rezaei, K. Abolmaali (Tehran, Iran). Lung manifestations of chronic granulomatous disease; a clinical survey of patients from the Iranian primary immunodeficiency registry. Eur Respir J 2001; 16: Suppl. 31, 3431
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Related content which might interest you:
The clinical spectrum of respiratory diseases in patients with primary humeoral immunodeficiency disorders; a clinical survey of patients from the Iranian primary immunodeficiency registry
Source: Eur Respir J 2001; 18: Suppl. 33, 510s
Year: 2001
Progression to a severe form of COVID-19 among patients with chronic respiratory diseases: a French multicentric study.
Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Year: 2021
Prevalence and characteristics of self-reported hypothyroidism and its association with nonorgan-specific manifestations in US sarcoidosis patients: a nationwide registry study
Source: ERJ Open Res, 7 (1) 00754-2020; 10.1183/23120541.00754-2020
Year: 2021
Ocular manifestations in unselected group of sarcoid patients hospitalised in the national tuberculosis and lung diseases research institute
Source: Eur Respir J 2002; 20: Suppl. 38, 435s
Year: 2002
PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
What are the most common respiratory diseases encountered in clinical practice? Results of a pilot study in 737 Indian patients
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
Association between congenital pulmonary disease and primary immunodeficiency in the bronchiectasis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 376s
Year: 2005
Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006
Pulmonary manifestations in adult patients with chronic granulomatous disease
Source: Eur Respir J 2015; 45: 1613-1623
Year: 2015
Rheumatoid arthritis and comorbid chronic obstructive or interstitial pulmonary diseases: Prevalence in a population-based cohort
Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption
Year: 2016
Does the HLA-DRB1-genotype influence the course of disease in Danish sarcoidosis patients?
Source: Annual Congress 2013 –Sarcoidosis
Year: 2013
How could we objectively measure lung disease severity in children with severe combined immunodeficiency?
Source: Annual Congress 2005 - New insights in respiratory infections in children
Year: 2005
PROOF-registry: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting
Source: International Congress 2014 – ILDs 6
Year: 2014
Outcomes in a cohort of childhood chronic cough: raised incidence of primary immunodeficiency
Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans
Year: 2019
Chronic pulmonary aspergillosis in France: prevalence, associated chronic pulmonary diseases and prognosis in a 10-year retrospective study of the French nationwide administrative hospital database.
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019
Interstitial pneumonia with autoimmune features associated with myositis autoantibodies: clinical characteristics from a multicenter Latin-American cohort.
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
Source: Eur Respir J 2015; 46: 186-196
Year: 2015
Pulmonary manifestations in adult patients with chronic granulomatous disease
Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Year: 2013
Outcomes of patients with progressive fibrosing interstitial lung disease (PF-ILD) – data from a prospective ILD registry
Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis
Year: 2021
Diagnostic latency and pulmonary morbidity in adult patients with primary immunodeficiency (PID): A single center experience
Source: International Congress 2015 – Clinical problems in acute and chronic lung diseases
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept